Wigginton Jon Marc 4
4 · MACROGENICS INC · Filed Mar 6, 2018
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Wigginton Jon Marc
Senior VP, Clinical Dev.
Transactions
- Award
Employee stock option (right to buy)
2018-03-02+70,000→ 70,000 totalExercise: $28.94Exp: 2028-03-02→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.